Screener
Kailera Therapeutics KLRA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Kailera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Kailera Therapeutics’s 10-Q, filed May 26, 2026.
- Filed
- May 26, 2026, 4:29 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-239417
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accounts payable | $7,095 | $7,529 |
| Accrued expenses and other current liabilities | 46,714 | 37,836 |
| Operating lease liabilities, current | 1,027 | 1,040 |
| Total current liabilities | 54,836 | 46,405 |
| Operating lease liabilities, non-current | 9,443 | 9,713 |
| Other non-current liabilities | 201 | 270 |
| Total liabilities | 64,480 | 56,388 |
| Commitments and contingencies (Note 12) |
Item 1. Financial Statements.
FAQ
- What is Kailera Therapeutics's total current liabilities?
- Kailera Therapeutics (KLRA) reported total current liabilities of $54.84M in Q1 2026.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Kailera Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude